Results 121 to 130 of about 11,066 (220)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). [PDF]

open access: yesJ Psychopharmacol, 2022
Kopra EI   +6 more
europepmc   +1 more source

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants. [PDF]

open access: yesClin Pharmacol Ther, 2021
Holze F   +9 more
europepmc   +1 more source

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. [PDF]

open access: yesNeuropsychopharmacology, 2022
Holze F   +12 more
europepmc   +1 more source

Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics. [PDF]

open access: yesPLoS Comput Biol
Zhang L   +9 more
europepmc   +1 more source

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). [PDF]

open access: yesDrug Test Anal, 2022
Brandt SD   +7 more
europepmc   +1 more source

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers. [PDF]

open access: yesBr J Pain
Cavarra M   +9 more
europepmc   +1 more source

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. [PDF]

open access: yesProc Natl Acad Sci U S A, 2021
De Gregorio D   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy